Literature DB >> 9261123

Cell-surface interactions of echovirus 22.

T Pulli1, E Koivunen, T Hyypiä.   

Abstract

Echovirus 22 (EV22) is a picornavirus forming a distinct molecular cluster together with echovirus 23. EV22 has an Arg-Gly-Asp (RGD) peptide motif in its capsid protein VP1; similar motifs are known to mediate many cell-cell and microbe-host interactions. To identify peptide sequences that specifically bind to EV22 and potentially play a role in receptor recognition, we have used here peptide libraries displayed in filamentous phage. We isolated an EV22-binding motif CLRSG(R/F)GC. The synthetic CLRSGRGC peptide was able to inhibit EV22 infection. The infection was also inhibited by an RGD-containing peptide representing the C terminus of the EV22 capsid protein VP1 and CWDDGWLC (an RGD-binding peptide; Pasqualini, R., Koivunen, E., and Ruoslahti, E. (1995) J. Cell Biol. 130, 1189-1196). As the EV22-recognizing sequence LRSG is found in the integrin beta1 chain and the entire LRSGRG hexapeptide occurs in the matrix metalloproteinase 9 (MMP-9), we carried out blocking experiments with anti-integrin and anti-MMP-9 antibodies. EV22 infection could be blocked in cell cultures with anti-alphav, -beta1, and, to a lesser extent, with anti-MMP-9 antibodies. These results imply that EV22 recognizes preferentially alphavbeta1-integrin as a cellular receptor and MMP-9 may also play a role in the cell-surface interactions of the virus.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9261123     DOI: 10.1074/jbc.272.34.21176

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Arginine-glycine-aspartic acid motif is critical for human parechovirus 1 entry.

Authors:  Y Boonyakiat; P J Hughes; F Ghazi; G Stanway
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  Foot-and-mouth disease virus virulent for cattle utilizes the integrin alpha(v)beta3 as its receptor.

Authors:  S Neff; D Sá-Carvalho; E Rieder; P W Mason; S D Blystone; E J Brown; B Baxt
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  Entry of human parechovirus 1.

Authors:  P Joki-Korpela; V Marjomäki; C Krogerus; J Heino; T Hyypiä
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

4.  High-efficiency utilization of the bovine integrin alpha(v)beta(3) as a receptor for foot-and-mouth disease virus is dependent on the bovine beta(3) subunit.

Authors:  S Neff; P W Mason; B Baxt
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

5.  Analysis of foot-and-mouth disease virus internalization events in cultured cells.

Authors:  Vivian O'Donnell; Michael LaRocco; Hernando Duque; Barry Baxt
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  RGD tripeptide of bluetongue virus VP7 protein is responsible for core attachment to Culicoides cells.

Authors:  B H Tan; E Nason; N Staeuber; W Jiang; K Monastryrskaya; P Roy
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

7.  Molecular analysis of three Ljungan virus isolates reveals a new, close-to-root lineage of the Picornaviridae with a cluster of two unrelated 2A proteins.

Authors:  Susanne Johansson; Bo Niklasson; Jacob Maizel; Alexander E Gorbalenya; A Michael Lindberg
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

8.  Interactions of foot-and-mouth disease virus with soluble bovine alphaVbeta3 and alphaVbeta6 integrins.

Authors:  Hernando Duque; Michael LaRocco; William T Golde; Barry Baxt
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Structural Basis of Human Parechovirus Neutralization by Human Monoclonal Antibodies.

Authors:  Shabih Shakeel; Brenda M Westerhuis; Ari Ora; Gerrit Koen; Arjen Q Bakker; Yvonne Claassen; Koen Wagner; Tim Beaumont; Katja C Wolthers; Sarah J Butcher
Journal:  J Virol       Date:  2015-07-08       Impact factor: 5.103

10.  Foot-and-mouth disease virus receptors: comparison of bovine alpha(V) integrin utilization by type A and O viruses.

Authors:  Hernando Duque; Barry Baxt
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.